Where are the Haldol and Aspirin Lawsuits and Hearings?

  • by: |
  • 12/21/2006
In the wake of sensationalist articles about Zyprexa and weight gain you would think that the next big story would be all those horrible side effects caused by typical antipsychotics like Haldol - which people like Robert Rosenheck and his cheerleaders inthe NY Times claim are just as good -- and cheaper -- than Zyprexa.

Some of Haldol's side effects.
The risk of tardive dyskinesia is around 4% per year in younger patients, higher than with most other antipsychotic drugs. In patients over the age of 45, the percentage of those afflicted can be even higher. Other predispositive factors may be female gender, prexisting affective disorder and cerebral dysfunction. See chlorpromazine for further details.
Other side effects include dry mouth, lethargy, muscle-stiffness, muscle-cramping, restlessness, tremors, and weight-gain; side effects like these are more likely to occur when the drug is given in high doses and/or during long-term treatment. Depression, severe enough to result in suicide, is quite often seen during long-term treatment.

Oh, and then there's the 'revelation' that painkillers like aspirin cause more liver injury than, say, Ketek, Senator Grassley's drug of choice.

Where are the Haldol and aspirin lawsuits? Or at least where are they in proportion to lawsuits against Lilly for weight gain associated with Zyprexa or Sanofi for 12 cases of liver injury?

Slip and fall litigation is pursued without regard to public health risk but with respect to profit.

So for those of you who commented about our earlier posts regarding the source of legal documents (and more on that later) it does matter. As long as journalists think its kosher to report the sources of income of respected academic researchers in the same sentence as they report what they say about a subject, we believe it is kosher to request that they report the source of everyone's income, particularly if that information source has a vested interest in the outcome of the case or decision that the reporter is writing about.

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
Better Health
Biotech Blog
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
Envisioning 2.0
FDA Law Blog
Fierce Pharma
Fresh Air Fund
Furious Seasons
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
In the Pipeline
In Vivo
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
More than Medicine
National Review
Neuroethics & Law
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmacology Corner
Pharmaceutical Business Review
Piper Report
Prescription for a Cure
Public Plan Facts
Real Clear Politics
Shark Report
Shearlings Got Plowed
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog